Cargando…

Quality of life in black African patients with keloid scars

A keloid scar is a benign skin tumor and we aimed to assess the Quality of Life (QoL) of black Africans with keloid scars based on the Dermatology Life Quality Index (DLQI). We conducted a cross-sectional descriptive study in the department of dermatology of the teaching hospital of Treichville in I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassi, Komenan, Kouame, Kanga, Kouassi, Alexandre, Allou, Ange, Kouassi, Isidore, Kourouma, Sarah, Ecra, Elidje, Sangare, Abdoulaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772769/
https://www.ncbi.nlm.nih.gov/pubmed/33408828
http://dx.doi.org/10.4081/dr.2020.8312
_version_ 1783629938291638272
author Kassi, Komenan
Kouame, Kanga
Kouassi, Alexandre
Allou, Ange
Kouassi, Isidore
Kourouma, Sarah
Ecra, Elidje
Sangare, Abdoulaye
author_facet Kassi, Komenan
Kouame, Kanga
Kouassi, Alexandre
Allou, Ange
Kouassi, Isidore
Kourouma, Sarah
Ecra, Elidje
Sangare, Abdoulaye
author_sort Kassi, Komenan
collection PubMed
description A keloid scar is a benign skin tumor and we aimed to assess the Quality of Life (QoL) of black Africans with keloid scars based on the Dermatology Life Quality Index (DLQI). We conducted a cross-sectional descriptive study in the department of dermatology of the teaching hospital of Treichville in Ivory Coast. We recruited 132 patients with keloid and 3612 dermatoses without keloid: The prevalence was 3.50% (132/3753). We included 120 patients aged from 16 to 63 years old, the sex ratio was 0.46 (38/82) and the mean age was 34.20 years. Keloid scars were mostly secondary to skin trauma in 30.00 % and infection in 21.67%. The commonest site was the ear in 29.17 %. We reported Keloid with pain in 53.33% and pruritus in 95.00%. We observed psychological impact in 65.83%. The DLQI scores were moderate and high in 61.66 %. QoL was impacted significantly when keloid was associated with pain (p=0.046), pruritus (p=0.81) and functional disorders (p=0.29). The DLQI score could be a valuable tool to assess QoL in black African patients with keloid, for better treatment option.
format Online
Article
Text
id pubmed-7772769
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-77727692021-01-05 Quality of life in black African patients with keloid scars Kassi, Komenan Kouame, Kanga Kouassi, Alexandre Allou, Ange Kouassi, Isidore Kourouma, Sarah Ecra, Elidje Sangare, Abdoulaye Dermatol Reports Article A keloid scar is a benign skin tumor and we aimed to assess the Quality of Life (QoL) of black Africans with keloid scars based on the Dermatology Life Quality Index (DLQI). We conducted a cross-sectional descriptive study in the department of dermatology of the teaching hospital of Treichville in Ivory Coast. We recruited 132 patients with keloid and 3612 dermatoses without keloid: The prevalence was 3.50% (132/3753). We included 120 patients aged from 16 to 63 years old, the sex ratio was 0.46 (38/82) and the mean age was 34.20 years. Keloid scars were mostly secondary to skin trauma in 30.00 % and infection in 21.67%. The commonest site was the ear in 29.17 %. We reported Keloid with pain in 53.33% and pruritus in 95.00%. We observed psychological impact in 65.83%. The DLQI scores were moderate and high in 61.66 %. QoL was impacted significantly when keloid was associated with pain (p=0.046), pruritus (p=0.81) and functional disorders (p=0.29). The DLQI score could be a valuable tool to assess QoL in black African patients with keloid, for better treatment option. PAGEPress Publications, Pavia, Italy 2020-10-22 /pmc/articles/PMC7772769/ /pubmed/33408828 http://dx.doi.org/10.4081/dr.2020.8312 Text en ©Copyright: the Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Kassi, Komenan
Kouame, Kanga
Kouassi, Alexandre
Allou, Ange
Kouassi, Isidore
Kourouma, Sarah
Ecra, Elidje
Sangare, Abdoulaye
Quality of life in black African patients with keloid scars
title Quality of life in black African patients with keloid scars
title_full Quality of life in black African patients with keloid scars
title_fullStr Quality of life in black African patients with keloid scars
title_full_unstemmed Quality of life in black African patients with keloid scars
title_short Quality of life in black African patients with keloid scars
title_sort quality of life in black african patients with keloid scars
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772769/
https://www.ncbi.nlm.nih.gov/pubmed/33408828
http://dx.doi.org/10.4081/dr.2020.8312
work_keys_str_mv AT kassikomenan qualityoflifeinblackafricanpatientswithkeloidscars
AT kouamekanga qualityoflifeinblackafricanpatientswithkeloidscars
AT kouassialexandre qualityoflifeinblackafricanpatientswithkeloidscars
AT allouange qualityoflifeinblackafricanpatientswithkeloidscars
AT kouassiisidore qualityoflifeinblackafricanpatientswithkeloidscars
AT kouroumasarah qualityoflifeinblackafricanpatientswithkeloidscars
AT ecraelidje qualityoflifeinblackafricanpatientswithkeloidscars
AT sangareabdoulaye qualityoflifeinblackafricanpatientswithkeloidscars